NCT04389112
- Conditions
- Basal Cell Carcinomas, Carcinoma, Carcinoma, Basal Cell, +10 more
- Locations
-
- Hôpital Saint-André - CHU de Bordeaux Bordeaux, France
Clinical trial condition
Precancerous Conditions
Explore clinical trials studying Precancerous Conditions. Study availability and eligibility vary by location and protocol.
888 public trials
124 recruiting studies
Precancerous Conditions trial results
NCT07653191
- Conditions
- Cervical Intraepithelial Neoplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Adana City Training and Research Hospital Adana, Turkey (Türkiye)
NCT03839459
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- University of Rochester Rochester, New York, United States
NCT03301220
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
- Innovative Clinical Research Inc Whittier, California, United States
- Miami Cancer Institute Miami, Florida, United States
- Emory University Atlanta, Georgia, United States
NCT01222286
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mount Sinai School of Medicine New York, United States
- Ohio State University Columbus, Ohio, United States
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
NCT06519994
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Cervical Precancer, +24 more
- Locations
-
- Lumumba Sub-County Hospital KEMRI- Research Care Training Program (RCTP) Building Kisumu, Kenya
NCT04731844
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Genital Diseases, +27 more
- Locations
-
- University of Rochester Rochester, New York, United States
Completed
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
NCT02316106
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Little Rock, Arkansas, United States
- Jacksonville, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States
NCT03076918
- Conditions
- Keratosis, Keratosis, Actinic, Neoplasms, +3 more
- Locations
-
- CHRU, Hôpital Claude Huriez Lille, France
NCT05132114
- Conditions
- Cervical Dysplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
- Locations
-
- Marien Hospital Herne Herne, North Rhine-Westphalia, Germany